{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T15:34:49Z","timestamp":1782401689315,"version":"3.54.5"},"reference-count":69,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,1,24]],"date-time":"2024-01-24T00:00:00Z","timestamp":1706054400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p><jats:bold>Introduction:<\/jats:bold> Hepatic steatosis is a hepatic pathological change closely associated with metabolic disorders, commonly observed in various metabolic diseases such as metabolic syndrome (MetS), with a high global prevalence. Dai-Zong-Fang (DZF), a traditional Chinese herbal formula, is widely used in clinical treatment for MetS, exhibiting multifaceted effects in reducing obesity and regulating blood glucose and lipids. This study aims to explore the mechanism by which DZF modulates the gut microbiota and reduces hepatic steatosis based on the gut-liver axis.<\/jats:p><jats:p><jats:bold>Methods:<\/jats:bold> This study utilized <jats:italic>db\/db<\/jats:italic> mice as a disease model for drug intervention. Body weight and fasting blood glucose were monitored. Serum lipid and transaminase levels were measured. Insulin tolerance test was conducted to assess insulin sensitivity. Hematoxylin and eosin (HE) staining was employed to observe morphological changes in the liver and intestine. The degree of hepatic steatosis was evaluated through Oil Red O staining and hepatic lipid determination. Changes in gut microbiota were assessed using 16S rRNA gene sequencing. Serum lipopolysaccharide (LPS) levels were measured by ELISA. The expression levels of intestinal tight junction proteins, intestinal lipid absorption-related proteins, and key proteins in hepatic lipid metabolism were examined through Western blot and RT-qPCR.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> After DZF intervention, there was a decrease in body weight, alleviation of glucose and lipid metabolism disorders, reduction in serum aspartate aminotransferase (AST) and alanine aminotransferase (ALT) levels, and mitigation of insulin resistance in mice. DZF significantly modulated the diversity of the gut microbiota, with a notable increase in the abundance of the <jats:italic>Bacteroidetes<\/jats:italic> phylum. PICRUSt indicated that DZF influenced various functions in gut microbiota, including carbohydrate and amino acid metabolism. Following DZF intervention, serum LPS levels decreased, intestinal pathological damage was reduced, and the expression of intestinal tight junction protein occludin was increased, while the expression of intestinal lipid absorption-related proteins cluster of differentiation 36 (CD36) and apolipoprotein B48 (ApoB48) were decreased. In the liver, DZF intervention resulted in a reduction in hepatic steatosis and lipid droplets, accompanied by a decrease fatty acid synthase (FASN) and stearoyl-CoA desaturase 1 (SCD1) and fatty acid transport protein 2 (FATP2). Conversely, there was an increase in the expression of the fatty acid oxidation-related enzyme carnitine palmitoyltransferase-1\ud835\udec2 (CPT-1\ud835\udec2).<\/jats:p><jats:p><jats:bold>Conclusion:<\/jats:bold> DZF can regulate the structure and function of the intestinal microbiota in <jats:italic>db\/db<\/jats:italic> mice. This ameliorates intestinal barrier damage and the detrimental effects of endotoxemia on hepatic metabolism. DZF not only inhibits intestinal lipid absorption but also improves hepatic lipid metabolism from various aspects, including <jats:italic>de novo<\/jats:italic> lipogenesis, fatty acid uptake, and fatty acid oxidation. This suggests that DZF may act on the liver and intestine as target organs, exerting its effects by improving the intestinal microbiota and related barrier and lipid absorption functions, ultimately ameliorating hepatic steatosis and enhancing overall glucose and lipid metabolism.<\/jats:p>","DOI":"10.3389\/fphar.2024.1337057","type":"journal-article","created":{"date-parts":[[2024,1,24]],"date-time":"2024-01-24T04:32:12Z","timestamp":1706070732000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Traditional Chinese Medicine formula Dai-Zong-Fang alleviating hepatic steatosis in db\/db mice via gut microbiota modulation"],"prefix":"10.3389","volume":"15","author":[{"given":"Li-Wei","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Li","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Yun","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shou-Qiang","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi-Ming","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,1,24]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1159\/000525925","article-title":"Alteration of the gut microbiome in inflammatory bowel disease","volume":"104","author":"Andoh","year":"2023","journal-title":"Digestion"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1005318","DOI":"10.3389\/fcimb.2022.1005318","article-title":"Effects of Zhishi Daozhi Decoction on the intestinal flora of nonalcoholic fatty liver disease mice induced by a high-fat diet","volume":"12","author":"Bi","year":"2022","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1038\/s41574-020-00427-4","article-title":"Circadian rhythms and the gut microbiota: from the metabolic syndrome to cancer","volume":"16","author":"Bishehsari","year":"2020","journal-title":"Nat. Rev. Endocrinol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"115571","DOI":"10.1016\/j.biopha.2023.115571","article-title":"Berberine: an inspiring resource for the treatment of colorectal diseases","volume":"167","author":"Cao","year":"2023","journal-title":"Biomed. Pharmacother. Biomedecine Pharmacother."},{"key":"B5","doi-asserted-by":"publisher","first-page":"438","DOI":"10.3390\/ijms20020438","article-title":"Gut microbiota and predicted metabolic pathways in a sample of Mexican women affected by obesity and obesity plus metabolic syndrome","volume":"20","author":"Ch\u00e1vez-Carbajal","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"B6","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1002\/cphy.c170026","article-title":"Intestinal CD36 and other key proteins of lipid utilization: role in absorption and gut homeostasis","volume":"8","author":"Cifarelli","year":"2018","journal-title":"Compr. Physiol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1038\/s41579-022-00805-x","article-title":"Bile acids and the gut microbiota: metabolic interactions and impacts on disease","volume":"21","author":"Collins","year":"2023","journal-title":"Nat. Rev. Microbiol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1136\/gutjnl-2021-326789","article-title":"Gut microbiome and health: mechanistic insights","volume":"71","author":"de Vos","year":"2022","journal-title":"Gut"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.7150\/ijbs.65476","article-title":"Berberine ameliorates DSS-induced intestinal mucosal barrier dysfunction through microbiota-dependence and Wnt\/\u03b2-catenin pathway","volume":"18","author":"Dong","year":"2022","journal-title":"Int. J. Biol. Sci."},{"key":"B10","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.jhep.2020.03.039","article-title":"A new definition for metabolic dysfunction-associated fatty liver disease: an international expert consensus statement","volume":"73","author":"Eslam","year":"2020","journal-title":"J. Hepatol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1038\/s41575-021-00566-7","article-title":"Role of bile acids and their receptors in gastrointestinal and hepatic pathophysiology","volume":"19","author":"Fuchs","year":"2022","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"2993","DOI":"10.3390\/nu14142993","article-title":"Gut microbiota characteristics of people with obesity by meta-analysis of existing datasets","volume":"14","author":"Gong","year":"2022","journal-title":"Nutrients"},{"key":"B13","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1038\/nrm2391","article-title":"Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes","volume":"9","author":"Guilherme","year":"2008","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"104722","DOI":"10.1016\/j.phrs.2020.104722","article-title":"Berberine pharmacology and the gut microbiota: a hidden therapeutic link","volume":"155","author":"Habtemariam","year":"2020","journal-title":"Pharmacol. Res."},{"key":"B15","first-page":"58","article-title":"The general situation of clinical application and pharmacological study of\u201cXiaoxianxiong decoction.\u201d","volume":"27","author":"Han","year":"2018","journal-title":"Chin. J. Ethnomedicine Ethnopharmacy"},{"key":"B16","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1038\/s41564-022-01152-6","article-title":"Characterization of inositol lipid metabolism in gut-associated Bacteroidetes","volume":"7","author":"Heaver","year":"2022","journal-title":"Nat. Microbiol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1038\/s41579-023-00904-3","article-title":"The gut-liver axis and gut microbiota in health and liver disease","volume":"21","author":"Hsu","year":"2023","journal-title":"Nat. Rev. Microbiol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"116060","DOI":"10.1016\/j.jep.2022.116060","article-title":"Lian-Qu formula treats metabolic syndrome via reducing fat synthesis, insulin resistance and inflammation","volume":"306","author":"Huang","year":"","journal-title":"J. Ethnopharmacol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"6583","DOI":"10.1039\/d1fo03776e","article-title":"Red yeast rice dietary intervention reduces oxidative stress-related inflammation and improves intestinal microbiota","volume":"13","author":"Huang","year":"","journal-title":"Food Funct."},{"key":"B20","doi-asserted-by":"publisher","first-page":"4001","DOI":"10.1172\/JCI129188","article-title":"\u03b2 Cell dysfunction during progression of metabolic syndrome to type 2 diabetes","volume":"129","author":"Hudish","year":"2019","journal-title":"J. Clin. Invest."},{"key":"B21","doi-asserted-by":"publisher","first-page":"2471","DOI":"10.1038\/s41467-020-16274-w","article-title":"Sphingolipids produced by gut bacteria enter host metabolic pathways impacting ceramide levels","volume":"11","author":"Johnson","year":"2020","journal-title":"Nat. Commun."},{"key":"B22","doi-asserted-by":"publisher","first-page":"4350","DOI":"10.1039\/c9fo00302a","article-title":"Cinnamon subcritical water extract attenuates intestinal inflammation and enhances intestinal tight junction in a Caco-2 and RAW264.7 co-culture model","volume":"10","author":"Kim","year":"2019","journal-title":"Food Funct."},{"key":"B23","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1038\/s41575-019-0250-7","article-title":"Regulation of intestinal lipid metabolism: current concepts and relevance to disease","volume":"17","author":"Ko","year":"2020","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1016\/j.jhep.2023.01.024","article-title":"An adipocentric perspective on the development and progression of non-alcoholic fatty liver disease","volume":"78","author":"Lee","year":"2023","journal-title":"J. Hepatol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"658","DOI":"10.4093\/dmj.2019.0220","article-title":"Revisiting the bacterial phylum composition in metabolic diseases focused on host energy metabolism","volume":"44","author":"Lee","year":"2020","journal-title":"Diabetes Metab. J."},{"key":"B26","first-page":"1052","article-title":"Differentiation and treatment of \u201cstagnation\u201d in Treatise on Cold damage diseases and its prescription application","volume":"26","author":"Li","year":"2020","journal-title":"J. Basic Chin. Med."},{"key":"B27","doi-asserted-by":"publisher","first-page":"110270","DOI":"10.1016\/j.foodres.2021.110270","article-title":"Curcumin alleviates high-fat diet-induced hepatic steatosis and obesity in association with modulation of gut microbiota in mice","volume":"143","author":"Li","year":"","journal-title":"Food Res. Int."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1016\/j.ijbiomac.2021.05.077","article-title":"Preparation and characterization of native and autoclaving-cooling treated Pinellia ternate starch and its impact on gut microbiota","volume":"182","author":"Li","year":"","journal-title":"Int. J. Biol. Macromol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1016\/j.tem.2021.04.008","article-title":"Links between metabolic syndrome and metabolic dysfunction-associated fatty liver disease","volume":"32","author":"Lim","year":"2021","journal-title":"Trends Endocrinol. Metab."},{"key":"B30","doi-asserted-by":"publisher","first-page":"545","DOI":"10.3920\/BM2016.0184","article-title":"Gut microbiota dysbiosis associated with glucose metabolism disorders and the metabolic syndrome in older adults","volume":"8","author":"Lippert","year":"2017","journal-title":"Benef. Microbes"},{"key":"B31","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1016\/j.carbpol.2018.10.041","article-title":"A polysaccharide extracted from Astragalus membranaceus residue improves cognitive dysfunction by altering gut microbiota in diabetic mice","volume":"205","author":"Liu","year":"2019","journal-title":"Carbohydr. Polym."},{"key":"B32","doi-asserted-by":"publisher","first-page":"12675","DOI":"10.1021\/acs.jafc.9b04879","article-title":"Nutritionally attenuating the human gut microbiome to prevent and manage metabolic syndrome","volume":"67","author":"Louis-Jean","year":"2019","journal-title":"J. Agric. Food Chem."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.3390\/nu12051474","article-title":"The firmicutes\/bacteroidetes ratio: a relevant marker of gut dysbiosis in obese patients?","volume":"12","author":"Magne","year":"2020","journal-title":"Nutrients"},{"key":"B34","doi-asserted-by":"publisher","first-page":"660179","DOI":"10.3389\/fimmu.2021.660179","article-title":"The role of the gut-liver Axis in metabolic dysfunction-associated fatty liver disease","volume":"12","author":"Mart\u00edn-Mateos","year":"2021","journal-title":"Front. Immunol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1017\/S0029665121003761","article-title":"Dysregulation of hepatic metabolism with obesity: factors influencing glucose and lipid metabolism","volume":"81","author":"Nagarajan","year":"2022","journal-title":"Proc. Nutr. Soc."},{"key":"B36","doi-asserted-by":"publisher","first-page":"101122","DOI":"10.1016\/j.molmet.2020.101122","article-title":"Nonalcoholic fatty liver disease (NAFLD) from pathogenesis to treatment concepts in humans","volume":"50","author":"Pafili","year":"2021","journal-title":"Mol. Metab."},{"key":"B37","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1038\/s43587-023-00389-y","article-title":"Longevity of centenarians is reflected by the gut microbiome with youth-associated signatures","volume":"3","author":"Pang","year":"2023","journal-title":"Nat. Aging"},{"key":"B38","doi-asserted-by":"publisher","first-page":"1520","DOI":"10.1039\/d2fo01835g","article-title":"Cinnamon (Cinnamomum cassia) water extract improves diarrhea symptoms by changing the gut environment: a randomized controlled trial","volume":"14","author":"Park","year":"2023","journal-title":"Food Funct."},{"key":"B39","doi-asserted-by":"publisher","first-page":"e13649","DOI":"10.14814\/phy2.13649","article-title":"Fecal Enterobacteriales enrichment is associated with increased in vivo intestinal permeability in humans","volume":"6","author":"Pedersen","year":"2018","journal-title":"Physiol. Rep."},{"key":"B40","doi-asserted-by":"publisher","first-page":"2212","DOI":"10.1016\/S0140-6736(20)32511-3","article-title":"Non-alcoholic fatty liver disease","volume":"397","author":"Powell","year":"2021","journal-title":"Lancet"},{"key":"B41","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1038\/s42255-019-0145-5","article-title":"Inter-organ cross-talk in metabolic syndrome","volume":"1","author":"Priest","year":"2019","journal-title":"Nat. Metab."},{"key":"B42","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1146\/annurev-animal-021419-083852","article-title":"The gut-liver Axis in the control of energy metabolism and food intake in animals","volume":"8","author":"Ringseis","year":"2020","journal-title":"Annu. Rev. Anim. Biosci."},{"key":"B43","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/s0022-2275(20)36881-4","article-title":"Determinants of intestinal mucosal uptake of short- and medium-chain fatty acids and alcohols","volume":"14","author":"Sallee","year":"1973","journal-title":"J. Lipid Res."},{"key":"B44","doi-asserted-by":"publisher","first-page":"e00939","DOI":"10.1128\/IAI.00939-19","article-title":"Gut epithelial metabolism as a key driver of intestinal dysbiosis associated with noncommunicable diseases","volume":"88","author":"Shelton","year":"2020","journal-title":"Infect. Immun."},{"key":"B45","first-page":"253","article-title":"Research progress on pharmacological mechanism of Xiaoxianxiong decoction in the treatment of cardiovascular diseases","volume":"32","author":"Shen","year":"2022","journal-title":"Pharm. Today"},{"key":"B46","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1111\/apt.16602","article-title":"Review article: therapeutic aspects of bile acid signalling in the gut\u2010liver axis","volume":"54","author":"Simbrunner","year":"2021","journal-title":"Aliment. Pharmacol. Ther."},{"key":"B47","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1016\/S2213-8587(23)00086-4","article-title":"Metabolic health and cardiometabolic risk clusters: implications for prediction, prevention, and treatment","volume":"11","author":"Stefan","year":"2023","journal-title":"Lancet Diabetes Endocrinol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s10863-021-09927-y","article-title":"Gualou Xiebai Decoction ameliorates increased Caco-2 monolayer permeability induced by bile acids via tight junction regulation, oxidative stress suppression and apoptosis reduction","volume":"54","author":"Su","year":"2022","journal-title":"J. Bioenerg. Biomembr."},{"key":"B49","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1038\/s41586-023-06466-x","article-title":"Gut microbial carbohydrate metabolism contributes to insulin resistance","volume":"621","author":"Takeuchi","year":"2023","journal-title":"Nature"},{"key":"B50","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1038\/s41586-020-2039-9","article-title":"Feeding-dependent VIP neuron-ILC3 circuit regulates the intestinal barrier","volume":"579","author":"Talbot","year":"2020","journal-title":"Nature"},{"key":"B51","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.1016\/j.cmet.2022.09.017","article-title":"Gut-liver axis: pathophysiological concepts and clinical implications","volume":"34","author":"Tilg","year":"2022","journal-title":"Cell Metab."},{"key":"B52","doi-asserted-by":"publisher","first-page":"5547","DOI":"10.1039\/D1FO04253J","article-title":"Protective role of bayberry extract: associations with gut microbiota modulation and key metabolites","volume":"13","author":"Tu","year":"2022","journal-title":"Food Funct."},{"key":"B53","doi-asserted-by":"publisher","first-page":"56","DOI":"10.3390\/biom12010056","article-title":"Understanding the role of the gut microbiome and microbial metabolites in non-alcoholic fatty liver disease: current evidence and perspectives","volume":"12","author":"Vallianou","year":"2021","journal-title":"Biomolecules"},{"key":"B54","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1136\/gutjnl-2021-325177","article-title":"Two microbiota subtypes identified in irritable bowel syndrome with distinct responses to the low FODMAP diet","volume":"71","author":"Vervier","year":"2022","journal-title":"Gut"},{"key":"B55","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1021\/acs.jafc.9b06247","article-title":"Polysaccharide from rosa roxburghii tratt fruit attenuates hyperglycemia and hyperlipidemia and regulates colon microbiota in diabetic db\/db mice","volume":"68","author":"Wang","year":"2020","journal-title":"J. Agric. Food Chem."},{"key":"B56","doi-asserted-by":"publisher","first-page":"210","DOI":"10.3390\/cells10020210","article-title":"Berberine prevents disease progression of nonalcoholic steatohepatitis through modulating multiple pathways","volume":"10","author":"Wang","year":"2021","journal-title":"Cells"},{"key":"B57","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1210\/er.2019-00034","article-title":"The liver as an endocrine organ-linking NAFLD and insulin resistance","volume":"40","author":"Watt","year":"2019","journal-title":"Endocr. Rev."},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1101\/561209","article-title":"Blood metabolome signature predicts gut microbiome \u03b1-diversity in health and disease","author":"Wilmanski","year":"2019","journal-title":"Bioinformatics"},{"key":"B59","doi-asserted-by":"publisher","first-page":"e14742","DOI":"10.15252\/emmm.202114742","article-title":"When fat meets the gut-focus on intestinal lipid handling in metabolic health and disease","volume":"14","author":"Wit","year":"2022","journal-title":"EMBO Mol. Med."},{"key":"B60","doi-asserted-by":"publisher","first-page":"3705","DOI":"10.1002\/jcp.30841","article-title":"A critical role of AMP-activated protein kinase in regulating intestinal nutrient absorption, barrier function, and intestinal diseases","volume":"237","author":"Wu","year":"2022","journal-title":"J. Cell. Physiol."},{"key":"B61","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1016\/j.aninu.2021.09.010","article-title":"Dietary fatty acids in gut health: absorption, metabolism and function","volume":"7","author":"Xu","year":"2021","journal-title":"Anim. Nutr. Zhongguo Xu Mu Shou Yi Xue Hui"},{"key":"B62","doi-asserted-by":"publisher","first-page":"1176443","DOI":"10.3389\/fphar.2023.1176443","article-title":"The Chinese herbal medicine Dai-Zong-Fang promotes browning of white adipocytes in vivo and in vitro by activating PKA pathway to ameliorate obesity","volume":"14","author":"Xu","year":"2023","journal-title":"Front. Pharmacol."},{"key":"B63","doi-asserted-by":"publisher","first-page":"113573","DOI":"10.1016\/j.jep.2020.113573","article-title":"Tracking evidences of Coptis chinensis for the treatment of inflammatory bowel disease from pharmacological, pharmacokinetic to clinical studies","volume":"268","author":"Yang","year":"2021","journal-title":"J. Ethnopharmacol."},{"key":"B64","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/19490976.2020.1848158","article-title":"Gut Bacteroides species in health and disease","volume":"13","author":"Zafar","year":"2021","journal-title":"Gut Microbes"},{"key":"B65","volume-title":"Treatise on Cold damage diseases","author":"Zhang","year":"2005"},{"key":"B66","doi-asserted-by":"publisher","first-page":"1083788","DOI":"10.3389\/fimmu.2022.1083788","article-title":"Berberine a traditional Chinese drug repurposing: its actions in inflammation-associated ulcerative colitis and cancer therapy","volume":"13","author":"Zhu","year":"2022","journal-title":"Front. Immunol."},{"key":"B67","doi-asserted-by":"publisher","first-page":"224","DOI":"10.3389\/fphys.2018.00224","article-title":"Dai-Zong-Fang, A traditional Chinese herbal formula, ameliorates insulin resistance in db\/db mice","volume":"9","author":"Zhu","year":"2018","journal-title":"Front. Physiol."},{"key":"B68","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.13192\/j.issn.1000-1719.2017.09.032","article-title":"Clinical research of Dai-zong-fang in treatment for 38 cases of metabolic syndrome with glucose and lipid disorder","volume":"44","author":"Zhu","year":"2017","journal-title":"Liaoning J. Tradit. Chin. Med."},{"key":"B69","doi-asserted-by":"publisher","first-page":"114034","DOI":"10.1016\/j.biopha.2022.114034","article-title":"Polysaccharide-rich fractions from Enteromorpha prolifera improve hepatic steatosis and gut barrier integrity in high-fat diet-induced obese mice linking to modulation of gut microbiota","volume":"157","author":"Zou","year":"2023","journal-title":"Biomed. Pharmacother."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2024.1337057\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,24]],"date-time":"2024-01-24T04:32:22Z","timestamp":1706070742000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2024.1337057\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,24]]},"references-count":69,"alternative-id":["10.3389\/fphar.2024.1337057"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2024.1337057","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,24]]},"article-number":"1337057"}}